NCT06431490 2026-04-08
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Shanghai Guangsheng Biopharmaceutical Co., Ltd